nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A4—Thiotepa—urinary bladder cancer	0.228	0.465	CbGbCtD
Dutasteride—CYP3A5—Etoposide—urinary bladder cancer	0.158	0.323	CbGbCtD
Dutasteride—SRD5A1—prostate gland—urinary bladder cancer	0.0672	0.311	CbGeAlD
Dutasteride—CYP3A4—Etoposide—urinary bladder cancer	0.0617	0.126	CbGbCtD
Dutasteride—SRD5A1—renal system—urinary bladder cancer	0.0458	0.212	CbGeAlD
Dutasteride—CYP3A4—Doxorubicin—urinary bladder cancer	0.0421	0.086	CbGbCtD
Dutasteride—SRD5A1—female reproductive system—urinary bladder cancer	0.0367	0.17	CbGeAlD
Dutasteride—CYP3A4—urine—urinary bladder cancer	0.0268	0.124	CbGeAlD
Dutasteride—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.0137	0.0489	CbGpPWpGaD
Dutasteride—CYP3A5—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.0136	0.0486	CbGpPWpGaD
Dutasteride—CYP3A5—prostate gland—urinary bladder cancer	0.0128	0.0593	CbGeAlD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0111	0.0394	CbGpPWpGaD
Dutasteride—CYP3A5—renal system—urinary bladder cancer	0.00874	0.0404	CbGeAlD
Dutasteride—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00718	0.0256	CbGpPWpGaD
Dutasteride—CYP3A4—renal system—urinary bladder cancer	0.00656	0.0303	CbGeAlD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00643	0.0229	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00643	0.0229	CbGpPWpGaD
Dutasteride—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00634	0.0226	CbGpPWpGaD
Dutasteride—CYP3A5—vagina—urinary bladder cancer	0.00633	0.0293	CbGeAlD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.0053	0.0189	CbGpPWpGaD
Dutasteride—CYP3A4—female reproductive system—urinary bladder cancer	0.00525	0.0243	CbGeAlD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00523	0.0186	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00514	0.0183	CbGpPWpGaD
Dutasteride—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.00452	0.0161	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0043	0.0153	CbGpPWpGaD
Dutasteride—CYP3A5—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00428	0.0153	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00388	0.0138	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTZ1—urinary bladder cancer	0.00367	0.0131	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTZ1—urinary bladder cancer	0.00367	0.0131	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTO2—urinary bladder cancer	0.00348	0.0124	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NAT1—urinary bladder cancer	0.00348	0.0124	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTO2—urinary bladder cancer	0.00348	0.0124	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NAT1—urinary bladder cancer	0.00348	0.0124	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00342	0.0122	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00342	0.0122	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—UGT2B7—urinary bladder cancer	0.00318	0.0113	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—UGT2B7—urinary bladder cancer	0.00318	0.0113	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTZ1—urinary bladder cancer	0.00293	0.0104	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00289	0.0103	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP4B1—urinary bladder cancer	0.00287	0.0102	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP4B1—urinary bladder cancer	0.00287	0.0102	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTO2—urinary bladder cancer	0.00277	0.00988	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.00277	0.00988	CbGpPWpGaD
Dutasteride—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.00277	0.00987	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00274	0.00974	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC19A1—urinary bladder cancer	0.00271	0.00964	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC19A1—urinary bladder cancer	0.00271	0.00964	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PRSS3—urinary bladder cancer	0.00264	0.00939	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PRSS3—urinary bladder cancer	0.00264	0.00939	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.00254	0.00904	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.0025	0.00891	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00247	0.00878	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00243	0.00867	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.00228	0.00814	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00225	0.00802	CbGpPWpGaD
Dutasteride—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00212	0.00756	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00211	0.00753	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00211	0.00753	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TYMP—urinary bladder cancer	0.00211	0.00751	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TYMP—urinary bladder cancer	0.00211	0.00751	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00202	0.00721	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00202	0.00721	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.002	0.00712	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00199	0.00709	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NAT2—urinary bladder cancer	0.00191	0.00679	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NAT2—urinary bladder cancer	0.00191	0.00679	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—RRM2—urinary bladder cancer	0.00165	0.00586	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—RRM2—urinary bladder cancer	0.00165	0.00586	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HPGDS—urinary bladder cancer	0.00152	0.00543	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HPGDS—urinary bladder cancer	0.00152	0.00543	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ENO2—urinary bladder cancer	0.00152	0.00543	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ENO2—urinary bladder cancer	0.00152	0.00543	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.00152	0.00541	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00152	0.0054	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00152	0.0054	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.0015	0.00534	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTT1—urinary bladder cancer	0.00148	0.00527	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTT1—urinary bladder cancer	0.00148	0.00527	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00146	0.00518	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00146	0.00518	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.00136	0.00484	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00134	0.00478	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00129	0.00459	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00129	0.00459	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00127	0.00453	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NQO1—urinary bladder cancer	0.00123	0.00438	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NQO1—urinary bladder cancer	0.00123	0.00438	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.00121	0.00433	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.00119	0.00425	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.00119	0.00425	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.00118	0.0042	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.00118	0.0042	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00116	0.00414	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00106	0.00378	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00105	0.00373	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00104	0.0037	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00104	0.0037	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTP1—urinary bladder cancer	0.00102	0.00365	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTP1—urinary bladder cancer	0.00102	0.00365	CbGpPWpGaD
Dutasteride—Breast cancer—Gemcitabine—urinary bladder cancer	0.001	0.0745	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000991	0.00353	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000991	0.00353	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TYMS—urinary bladder cancer	0.000953	0.00339	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TYMS—urinary bladder cancer	0.000953	0.00339	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTM1—urinary bladder cancer	0.000942	0.00335	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTM1—urinary bladder cancer	0.000942	0.00335	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NCOR1—urinary bladder cancer	0.000942	0.00335	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NCOR1—urinary bladder cancer	0.000942	0.00335	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000915	0.00326	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GPX1—urinary bladder cancer	0.000902	0.00321	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GPX1—urinary bladder cancer	0.000902	0.00321	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ERCC2—urinary bladder cancer	0.000885	0.00315	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ERCC2—urinary bladder cancer	0.000885	0.00315	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—MTHFR—urinary bladder cancer	0.000832	0.00296	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MTHFR—urinary bladder cancer	0.000832	0.00296	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000817	0.00291	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000806	0.00287	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000751	0.00267	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00074	0.00264	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000706	0.00252	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000697	0.00248	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PPARG—urinary bladder cancer	0.000675	0.0024	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PPARG—urinary bladder cancer	0.000675	0.0024	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CREBBP—urinary bladder cancer	0.000648	0.00231	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CREBBP—urinary bladder cancer	0.000648	0.00231	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000565	0.00201	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000548	0.00195	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS2—urinary bladder cancer	0.000531	0.00189	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS2—urinary bladder cancer	0.000531	0.00189	CbGpPWpGaD
Dutasteride—Neoplasm malignant—Thiotepa—urinary bladder cancer	0.00051	0.0379	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.0005	0.00178	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000474	0.00169	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000474	0.00169	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTEN—urinary bladder cancer	0.000463	0.00165	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTEN—urinary bladder cancer	0.000463	0.00165	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—EP300—urinary bladder cancer	0.000441	0.00157	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—EP300—urinary bladder cancer	0.000441	0.00157	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000434	0.00155	CbGpPWpGaD
Dutasteride—Neoplasm malignant—Gemcitabine—urinary bladder cancer	0.000429	0.0318	CcSEcCtD
Dutasteride—Tenderness—Gemcitabine—urinary bladder cancer	0.00042	0.0312	CcSEcCtD
Dutasteride—Tenderness—Fluorouracil—urinary bladder cancer	0.000413	0.0306	CcSEcCtD
Dutasteride—Loss of libido—Methotrexate—urinary bladder cancer	0.000406	0.0301	CcSEcCtD
Dutasteride—Tenderness—Cisplatin—urinary bladder cancer	0.000391	0.0291	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000391	0.00139	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.00038	0.00135	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000374	0.00133	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.000369	0.00131	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000359	0.00128	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000349	0.00124	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000344	0.00123	CbGpPWpGaD
Dutasteride—Cardiac failure—Thiotepa—urinary bladder cancer	0.000324	0.024	CcSEcCtD
Dutasteride—Pruritus—Valrubicin—urinary bladder cancer	0.000317	0.0236	CcSEcCtD
Dutasteride—Dizziness—Valrubicin—urinary bladder cancer	0.000296	0.022	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—TYMP—urinary bladder cancer	0.000287	0.00102	CbGpPWpGaD
Dutasteride—Rash—Valrubicin—urinary bladder cancer	0.000283	0.021	CcSEcCtD
Dutasteride—Dermatitis—Valrubicin—urinary bladder cancer	0.000282	0.021	CcSEcCtD
Dutasteride—Cardiac failure—Gemcitabine—urinary bladder cancer	0.000272	0.0202	CcSEcCtD
Dutasteride—Cardiac failure—Fluorouracil—urinary bladder cancer	0.000268	0.0199	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—NAT2—urinary bladder cancer	0.00026	0.000926	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	0.000233	0.000829	CbGpPWpGaD
Dutasteride—Cardiac failure—Etoposide—urinary bladder cancer	0.000233	0.0173	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—RRM2—urinary bladder cancer	0.000224	0.000799	CbGpPWpGaD
Dutasteride—Breast disorder—Cisplatin—urinary bladder cancer	0.000224	0.0166	CcSEcCtD
Dutasteride—Hyperaesthesia—Epirubicin—urinary bladder cancer	0.000223	0.0166	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	0.000221	0.000785	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NAT1—urinary bladder cancer	0.000221	0.000785	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ENO2—urinary bladder cancer	0.000208	0.00074	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	0.000208	0.00074	CbGpPWpGaD
Dutasteride—Hyperaesthesia—Doxorubicin—urinary bladder cancer	0.000207	0.0153	CcSEcCtD
Dutasteride—Neoplasm malignant—Epirubicin—urinary bladder cancer	0.000205	0.0152	CcSEcCtD
Dutasteride—Dizziness—Mitomycin—urinary bladder cancer	0.000204	0.0152	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	0.000202	0.000718	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	0.000202	0.000718	CbGpPWpGaD
Dutasteride—Breast pain—Epirubicin—urinary bladder cancer	0.000201	0.0149	CcSEcCtD
Dutasteride—Immune system disorder—Thiotepa—urinary bladder cancer	0.000197	0.0147	CcSEcCtD
Dutasteride—Rash—Mitomycin—urinary bladder cancer	0.000195	0.0145	CcSEcCtD
Dutasteride—Dermatitis—Mitomycin—urinary bladder cancer	0.000195	0.0144	CcSEcCtD
Dutasteride—Mental disorder—Thiotepa—urinary bladder cancer	0.000192	0.0142	CcSEcCtD
Dutasteride—Neoplasm malignant—Doxorubicin—urinary bladder cancer	0.00019	0.0141	CcSEcCtD
Dutasteride—Breast pain—Doxorubicin—urinary bladder cancer	0.000186	0.0138	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	0.000182	0.000647	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	0.000171	0.000611	CbGpPWpGaD
Dutasteride—Neoplasm—Methotrexate—urinary bladder cancer	0.000169	0.0126	CcSEcCtD
Dutasteride—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000168	0.0124	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—NQO1—urinary bladder cancer	0.000167	0.000596	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	0.000167	0.000595	CbGpPWpGaD
Dutasteride—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000166	0.0123	CcSEcCtD
Dutasteride—Neoplasm—Epirubicin—urinary bladder cancer	0.000158	0.0118	CcSEcCtD
Dutasteride—Immune system disorder—Cisplatin—urinary bladder cancer	0.000155	0.0115	CcSEcCtD
Dutasteride—Neoplasm—Doxorubicin—urinary bladder cancer	0.000147	0.0109	CcSEcCtD
Dutasteride—Immune system disorder—Etoposide—urinary bladder cancer	0.000142	0.0105	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	0.00014	0.000497	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TYMP—urinary bladder cancer	0.000134	0.000476	CbGpPWpGaD
Dutasteride—Cardiac failure—Epirubicin—urinary bladder cancer	0.00013	0.00968	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—TYMS—urinary bladder cancer	0.00013	0.000463	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	0.000128	0.000457	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	0.000128	0.000457	CbGpPWpGaD
Dutasteride—Urticaria—Thiotepa—urinary bladder cancer	0.000123	0.00916	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—GPX1—urinary bladder cancer	0.000123	0.000438	CbGpPWpGaD
Dutasteride—Breast disorder—Methotrexate—urinary bladder cancer	0.000123	0.00912	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—NAT2—urinary bladder cancer	0.000121	0.00043	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	0.000121	0.00043	CbGpPWpGaD
Dutasteride—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000121	0.00896	CcSEcCtD
Dutasteride—Breast disorder—Epirubicin—urinary bladder cancer	0.000115	0.00854	CcSEcCtD
Dutasteride—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000114	0.0085	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	0.000113	0.000404	CbGpPWpGaD
Dutasteride—Pruritus—Thiotepa—urinary bladder cancer	0.00011	0.00816	CcSEcCtD
Dutasteride—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000108	0.00804	CcSEcCtD
Dutasteride—Breast disorder—Doxorubicin—urinary bladder cancer	0.000106	0.0079	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—RRM2—urinary bladder cancer	0.000104	0.000371	CbGpPWpGaD
Dutasteride—Dizziness—Thiotepa—urinary bladder cancer	0.000103	0.00763	CcSEcCtD
Dutasteride—Urticaria—Fluorouracil—urinary bladder cancer	0.000102	0.00758	CcSEcCtD
Dutasteride—Rash—Thiotepa—urinary bladder cancer	9.79e-05	0.00727	CcSEcCtD
Dutasteride—Dermatitis—Thiotepa—urinary bladder cancer	9.78e-05	0.00727	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.66e-05	0.000344	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.66e-05	0.000344	CbGpPWpGaD
Dutasteride—Hypersensitivity—Fluorouracil—urinary bladder cancer	9.46e-05	0.00703	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.37e-05	0.000334	CbGpPWpGaD
Dutasteride—Pruritus—Gemcitabine—urinary bladder cancer	9.24e-05	0.00686	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—PPARG—urinary bladder cancer	9.2e-05	0.000328	CbGpPWpGaD
Dutasteride—Pruritus—Fluorouracil—urinary bladder cancer	9.09e-05	0.00675	CcSEcCtD
Dutasteride—Hypersensitivity—Cisplatin—urinary bladder cancer	8.97e-05	0.00666	CcSEcCtD
Dutasteride—Urticaria—Etoposide—urinary bladder cancer	8.86e-05	0.00658	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	8.84e-05	0.000315	CbGpPWpGaD
Dutasteride—Immune system disorder—Methotrexate—urinary bladder cancer	8.49e-05	0.00631	CcSEcCtD
Dutasteride—Dizziness—Fluorouracil—urinary bladder cancer	8.49e-05	0.00631	CcSEcCtD
Dutasteride—Mental disorder—Methotrexate—urinary bladder cancer	8.24e-05	0.00612	CcSEcCtD
Dutasteride—Rash—Gemcitabine—urinary bladder cancer	8.24e-05	0.00612	CcSEcCtD
Dutasteride—Dermatitis—Gemcitabine—urinary bladder cancer	8.23e-05	0.00611	CcSEcCtD
Dutasteride—Hypersensitivity—Etoposide—urinary bladder cancer	8.22e-05	0.0061	CcSEcCtD
Dutasteride—Rash—Fluorouracil—urinary bladder cancer	8.1e-05	0.00602	CcSEcCtD
Dutasteride—Dermatitis—Fluorouracil—urinary bladder cancer	8.09e-05	0.00601	CcSEcCtD
Dutasteride—Immune system disorder—Epirubicin—urinary bladder cancer	7.95e-05	0.0059	CcSEcCtD
Dutasteride—Pruritus—Etoposide—urinary bladder cancer	7.89e-05	0.00586	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.79e-05	0.000277	CbGpPWpGaD
Dutasteride—Mental disorder—Epirubicin—urinary bladder cancer	7.71e-05	0.00573	CcSEcCtD
Dutasteride—Rash—Cisplatin—urinary bladder cancer	7.68e-05	0.0057	CcSEcCtD
Dutasteride—Dermatitis—Cisplatin—urinary bladder cancer	7.67e-05	0.0057	CcSEcCtD
Dutasteride—Dizziness—Etoposide—urinary bladder cancer	7.38e-05	0.00548	CcSEcCtD
Dutasteride—Immune system disorder—Doxorubicin—urinary bladder cancer	7.36e-05	0.00546	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.24e-05	0.000258	CbGpPWpGaD
Dutasteride—Mental disorder—Doxorubicin—urinary bladder cancer	7.13e-05	0.0053	CcSEcCtD
Dutasteride—Rash—Etoposide—urinary bladder cancer	7.03e-05	0.00522	CcSEcCtD
Dutasteride—Dermatitis—Etoposide—urinary bladder cancer	7.03e-05	0.00522	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.49e-05	0.000231	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.31e-05	0.000225	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.04e-05	0.000215	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—EP300—urinary bladder cancer	6.02e-05	0.000214	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.97e-05	0.000213	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.97e-05	0.000213	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.71e-05	0.000204	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.61e-05	0.0002	CbGpPWpGaD
Dutasteride—Urticaria—Methotrexate—urinary bladder cancer	5.31e-05	0.00394	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.27e-05	0.000188	CbGpPWpGaD
Dutasteride—Urticaria—Epirubicin—urinary bladder cancer	4.97e-05	0.00369	CcSEcCtD
Dutasteride—Hypersensitivity—Methotrexate—urinary bladder cancer	4.92e-05	0.00366	CcSEcCtD
Dutasteride—Pruritus—Methotrexate—urinary bladder cancer	4.73e-05	0.00351	CcSEcCtD
Dutasteride—Hypersensitivity—Epirubicin—urinary bladder cancer	4.61e-05	0.00342	CcSEcCtD
Dutasteride—Urticaria—Doxorubicin—urinary bladder cancer	4.6e-05	0.00341	CcSEcCtD
Dutasteride—Pruritus—Epirubicin—urinary bladder cancer	4.42e-05	0.00329	CcSEcCtD
Dutasteride—Dizziness—Methotrexate—urinary bladder cancer	4.42e-05	0.00328	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.28e-05	0.000152	CbGpPWpGaD
Dutasteride—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.26e-05	0.00317	CcSEcCtD
Dutasteride—Rash—Methotrexate—urinary bladder cancer	4.21e-05	0.00313	CcSEcCtD
Dutasteride—Dermatitis—Methotrexate—urinary bladder cancer	4.21e-05	0.00313	CcSEcCtD
Dutasteride—Dizziness—Epirubicin—urinary bladder cancer	4.13e-05	0.00307	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.11e-05	0.000146	CbGpPWpGaD
Dutasteride—Pruritus—Doxorubicin—urinary bladder cancer	4.09e-05	0.00304	CcSEcCtD
Dutasteride—Rash—Epirubicin—urinary bladder cancer	3.94e-05	0.00293	CcSEcCtD
Dutasteride—Dermatitis—Epirubicin—urinary bladder cancer	3.94e-05	0.00293	CcSEcCtD
Dutasteride—Dizziness—Doxorubicin—urinary bladder cancer	3.83e-05	0.00284	CcSEcCtD
Dutasteride—Rash—Doxorubicin—urinary bladder cancer	3.65e-05	0.00271	CcSEcCtD
Dutasteride—Dermatitis—Doxorubicin—urinary bladder cancer	3.64e-05	0.00271	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.36e-05	0.00012	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.93e-05	0.000104	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.8e-05	9.97e-05	CbGpPWpGaD
